27th Annual Meeting attendees can watch all sessions on demand on the virtual platform through June 21!
Speakers, titles, times, and locations of ASGCT presentations
Thursday, May 09 2024 03:45 PM – 05:30 PM ETBallroom 1
There has been significant discussion among CGT developers about the opportunities and challenges of alternative manufacturing models, especially decentralized and point of care approaches. One of the greatest challenges to make these models a reality, however, is determining how to perform analytics for product release. This session will focus on that aspect, offering a regulatory overview of the different manufacturing models, a deep dive into analytics and how to enable them, and lessons from companies that are working to put these models into action.
03:45 PM - 05:30 PM - Ballroom 1
Katy Spink - PhD - Dark Horse Consulting Group
Sadik Kassim - PhD - Danaher Life Sciences
03:45 PM - 04:05 PM - Ballroom 1
Kimberly Schultz - FDA
04:05 PM - 04:25 PM - Ballroom 1
Therese Choquette - Ph.D - TigenPharma
04:25 PM - 04:45 PM - Ballroom 1
Rimas Orentas - PhD - Caring Cross, Inc.
04:45 PM - 05:05 PM - Ballroom 1
David Peritt - PhD - Lupagen Inc.
05:05 PM - 05:30 PM - Ballroom 1
David Peritt - Lupagen Inc.
Therese Choquette - Ph.D. - TigenPharma
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico